MarketCap
Vanda Pharmaceuticals VNDA
€ 3.54
0.13%
Facebook
X
Telegram
Vanda Pharmaceuticals EV | VNDA
EV Jährlich Vanda Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 435 M | 276 M | 201 M | 385 M | 908 M | 734 M | 719 M | 1.43 B | 765 M | 616 M | 390 M | 337 M | 431 M | 159 M | 200 M | 337 M | 176 M | -39.1 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.43 B | -39.1 M | 470 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Lumos Pharma
LUMO
|
2.85 M | - | - | $ 35.3 M |  USA |
 |
Syros Pharmaceuticals
SYRS
|
25.9 M | - | -8.44 % | $ 3.4 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
283 M | - | -18.25 % | $ 5.04 M |  Israel |
 |
Citius Pharmaceuticals
CTXR
|
57.7 M | $ 0.45 | 13.31 % | $ 4.98 M | USA |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
77.1 M | - | -74.18 % | $ 955 K | USA |
 |
Novo Nordisk A/S
NVO
|
541 B | $ 39.12 | 0.17 % | $ 174 B |  Danmark |
 |
Abeona Therapeutics
ABEO
|
234 M | $ 4.33 | -1.7 % | $ 229 M | USA |
 |
AIM ImmunoTech
AIM
|
13.7 M | $ 0.16 | 3.97 % | $ 259 K | USA |
 |
Akebia Therapeutics
AKBA
|
493 M | $ 0.63 | 11.85 % | $ 162 M | USA |
 |
Aldeyra Therapeutics
ALDX
|
284 M | $ 0.64 | -2.15 % | $ 38.4 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 228.15 | 1.84 % | $ 29.9 B | USA |
 |
Altimmune
ALT
|
329 M | $ 2.04 | -3.77 % | $ 180 M | USA |
 |
Assembly Biosciences
ASMB
|
301 M | $ 19.65 | -0.96 % | $ 220 M | USA |
 |
Ascendis Pharma A/S
ASND
|
14 B | $ 245.48 | 0.87 % | $ 14.9 B | Danmark |
 |
Beam Therapeutics
BEAM
|
3.15 B | $ 23.79 | -1.08 % | $ 2.35 B | USA |
 |
Benitec Biopharma
BNTC
|
388 M | $ 8.58 | -0.81 % | $ 399 M | USA |
 |
Capricor Therapeutics
CAPR
|
1.21 B | $ 5.72 | -3.54 % | $ 266 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Cerus Corporation
CERS
|
632 M | $ 2.37 | 1.5 % | $ 452 M | USA |
 |
Cullinan Management
CGEM
|
850 M | $ 14.55 | 1.25 % | $ 877 M | USA |
 |
Curis
CRIS
|
18.9 M | $ 0.38 | -2.33 % | $ 5 M | USA |
 |
CorMedix
CRMD
|
276 M | $ 7.95 | 1.27 % | $ 573 K | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 14.37 | 3.53 % | $ 929 M | USA |
 |
NuCana plc
NCNA
|
85.3 B | $ 1.03 | 4.54 % | $ 11.6 B |  Britain |
 |
BioVie
BIVI
|
-12.6 M | $ 1.33 | 7.26 % | $ 1.96 M | USA |
 |
CEL-SCI Corporation
CVM
|
21.1 M | $ 1.6 | -1.84 % | $ 12.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
59.5 M | $ 1.15 | -9.84 % | $ 60.4 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
1.97 B | $ 60.7 | -0.87 % | $ 7.29 M | USA |
 |
Daré Bioscience
DARE
|
21.8 M | $ 0.64 | -0.33 % | $ 7.15 M | USA |
 |
DBV Technologies S.A.
DBVT
|
2.69 B | $ 9.97 | 2.21 % | $ 1.39 B |  France |
 |
Denali Therapeutics
DNLI
|
2.34 B | $ 18.66 | 1.35 % | $ 3.22 B | USA |
 |
Precision BioSciences
DTIL
|
16 M | $ 6.4 | -3.61 % | $ 82.1 M | USA |
 |
Dyadic International
DYAI
|
35.6 M | $ 0.43 | 7.72 % | $ 15.6 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
434 M | $ 0.16 | -7.21 % | $ 7.31 M | Israel |
 |
Enanta Pharmaceuticals
ENTA
|
184 M | $ 12.0 | 3.09 % | $ 256 K | USA |
 |
Entera Bio Ltd.
ENTX
|
85.4 M | $ 2.83 | -3.25 % | $ 131 M | Israel |
 |
Passage Bio
PASG
|
10.1 M | $ 3.36 | -0.33 % | $ 10.8 M | USA |
|
Forte Biosciences
FBRX
|
280 M | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Exelixis
EXEL
|
11.9 B | $ 65.14 | 0.95 % | $ 17.7 B | USA |
|
Immatics N.V.
IMTX
|
389 M | $ 7.16 | -2.12 % | $ 876 M |  Germany |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Gilead Sciences
GILD
|
176 B | $ 158.71 | 1.71 % | $ 197 B | USA |
 |
Grifols, S.A.
GRFS
|
16.3 B | $ 7.91 | 4.56 % | $ 5.38 B |  Spain |
 |
GlaxoSmithKline plc
GSK
|
258 B | $ 51.12 | 0.73 % | $ 207 B | Britain |
 |
Halozyme Therapeutics
HALO
|
12 B | $ 128.07 | 1.94 % | $ 15.3 B | USA |
 |
Bio-Techne Corporation
TECH
|
11 B | $ 72.69 | 0.2 % | $ 11.3 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 36.84 | 1.97 % | $ 2.12 B | USA |
 |
Immuron Limited
IMRN
|
230 M | $ 0.96 | 0.25 % | $ 222 M |  Australia |
 |
Immunic
IMUX
|
160 M | $ 7.28 | -1.75 % | $ 1.13 B | USA |